Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer
Clinical trial NCT01631357 · COMPLETED
Trial details
- NCT number
- NCT01631357
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2018-12-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.